The value of the wireless stethoscope in patients with COVID-19 infection in a makeshift hospital.
Auscultation
COVID-19
Makeshift hospital
SARS-CoV-2
Wireless stethoscopes
Journal
Biomedical engineering online
ISSN: 1475-925X
Titre abrégé: Biomed Eng Online
Pays: England
ID NLM: 101147518
Informations de publication
Date de publication:
14 Jul 2023
14 Jul 2023
Historique:
received:
29
03
2023
accepted:
07
07
2023
medline:
17
7
2023
pubmed:
15
7
2023
entrez:
14
7
2023
Statut:
epublish
Résumé
When COVID-19 sweeps the world, traditional stethoscopes are seen as infectious agents and then the use of stethoscopes is limited especially when health providers were in their personal protective equipment. These reasons led to the ignoring of the values of stethoscopes during pandemics. This study aims to explore the value of wireless stethoscopes in patients of a makeshift hospital. 200 consecutive hospitalized patients with confirmed SARS-CoV-2 at Lingang Makeshift Hospital in Shanghai, China, were enrolled from April 10 to May 10, 2022 (Trial Registration Number: ChiCTR2000038272,2020/9/15). They were randomly divided into two groups. In group A (n = 100), patients were examined without a stethoscope. In group B (n = 100), lung breath sounds and heart sounds were examined with a wireless stethoscope, and positive signs were recorded. The duration of cough and tachycardia symptoms, as well as emergency cases, were compared between the two groups. In addition, the pressure, anxiety, and depression of patients in the two groups were investigated using the DAS-21 questionnaire scale, to observe the psychological impact of the stethoscope-based doctor-patient communication on patients in the makeshift hospital. There was no significant difference in baseline characteristics between the two groups. In group B, some significant positive signs were detected by wireless stethoscopes, including pulmonary rales and tachycardia, etc. Moreover, the therapeutic measures based on these positive signs effectively alleviated the symptoms of cough and tachycardia, which showed that the duration of symptoms was significantly shorter than that of group A (cough: 2.8 ± 0.9 vs. 3.6 ± 0.9; palpitation: 1.4 ± 0.7 vs. 2.6 ± 0.7). In particular, the number of emergency cases in group B is less than that in group A (1% vs. 3%), and the severity is lower. Notably, stethoscope-based doctor-patient communication was found to be effective in alleviating psychological measures of group B patients. Wireless stethoscopes in makeshift hospitals can avoid cross-infections and detect more valuable positive signs, which can help health providers make accurate decisions and relieve patients' symptoms more quickly. Moreover, stethoscope-based doctor-patient communication can diminish the psychological impacts of the epidemic on isolated patients in makeshift hospitals. Trial registration This study was registered in the Chinese Clinical Trial (ChiCTR2000038272) at http://www.chictr.org.cn . http://www.chinadrugtrials.org.cn/clinicaltrials.searchlistdetail.dhtml .
Identifiants
pubmed: 37452420
doi: 10.1186/s12938-023-01136-5
pii: 10.1186/s12938-023-01136-5
pmc: PMC10347834
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
71Subventions
Organisme : the National Major Science and Technology Infrastructure for Translational Medicine Open Project of Shanghai Jiao Tong University
ID : TMSK-2021-149
Organisme : Science and Technology Tackling Project of Shanghai Songjiang District Science and Technology Commission
ID : 2020SJ288
Organisme : Science and technology innovation project of Shanghai Chongming District Science and Technology Commission
ID : CKY2020-5
Organisme : National Natural Science Foundation of China
ID : 82270536
Organisme : the Medical Engineering Cross Research Fund of Shanghai Jiao Tong University
ID : YG2020YQ15
Commentaires et corrections
Type : ErratumIn
Informations de copyright
© 2023. The Author(s).
Références
Am J Med. 2022 Sep;135(9):1124-1133
pubmed: 35640698
J Chem Inf Model. 2022 Jan 24;62(2):412-422
pubmed: 34989238
N Engl J Med. 2001 Aug 23;345(8):574-81
pubmed: 11529211
Ann Intern Med. 2021 Aug;174(8):W91-W93
pubmed: 34310170
Chest. 2021 Jan;159(1):259-269
pubmed: 32653569
Med Hypotheses. 2021 Aug;153:110622
pubmed: 34130113
Eur Rev Med Pharmacol Sci. 2021 Dec;25(24):8012-8018
pubmed: 34982465
Int J Environ Res Public Health. 2020 Mar 06;17(5):
pubmed: 32155789
Biomed Eng Online. 2022 Sep 6;21(1):63
pubmed: 36068509
Mayo Clin Proc. 2014 Mar;89(3):291-9
pubmed: 24582188
J Med Virol. 2022 May;94(5):1821-1824
pubmed: 34936120
Adv Exp Med Biol. 2021;1321:229-236
pubmed: 33656727
Am J Med. 2020 Oct;133(10):1143-1150
pubmed: 32569591
J Am Coll Cardiol. 2016 Mar 8;67(9):1118-1119
pubmed: 26780238
Pediatrics. 2021 Jan;147(1):
pubmed: 32788269
J Am Heart Assoc. 2021 May 4;10(9):e019905
pubmed: 33899504
Lung. 2022 Dec;200(6):707-716
pubmed: 36227349
BMJ Open Respir Res. 2022 May;9(1):
pubmed: 35577452
Int J Med Sci. 2021 Jan 28;18(6):1415-1422
pubmed: 33628098
Infect Control Hosp Epidemiol. 2016 Jun;37(6):673-9
pubmed: 27198604